Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Clinical Trials, Phase II as Topic

"Clinical Trials, Phase II as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

Studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.


This graph shows the total number of publications written about "Clinical Trials, Phase II as Topic" by people in Harvard Catalyst Profiles by year, and whether "Clinical Trials, Phase II as Topic" was a major or minor topic of these publication.
Bar chart showing 324 publications over 28 distinct years, with a maximum of 33 publications in 2013
To see the data from this visualization as text, click here.
Related Networks
People
Explore
_
Similar Concepts
_
Top Journals 
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.